Paper7878469
Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms.
Jeffrey PD and 2 others. Science, 1995. Cited by 458 papers, by iCite.
Cite this record
ConductScience Library. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Papers, record 7878469. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7878469
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Protein Conformation | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Computer Graphics | |
| Crystallography, X-Ray | |
| DNA | |
| Hydrogen Bonding | |
| Macromolecular Substances | |
| Models, Molecular | |
| Protein Structure, Secondary |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA08748-29 | NCI NIH HHS | United States | PubMed | PubMed | |
| P01CA008748 | NIH | NIH RePORTER | |||
| P30CA008748 | NIH | NIH RePORTER |
Cited by212
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 458 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42432287 | Revisiting the p53:Sirt1 interaction in light of controlling p53 acetylation levels. | Commun Chem | 2026 | https://conductscience.org/library/papers/42432287 | PubMed |
| 42311239 | Biology of p53 protein isoforms and their significance in hematological malignancies. | Front Oncol | 2026 | https://conductscience.org/library/papers/42311239 | PubMed |
| 42143149 | Cancer-linked aggregation of p53 is driven by sequence-encoded frustration, solvation, and hydrophobic gating absent in its paralogs. | Commun Chem | 2026 | https://conductscience.org/library/papers/42143149 | PubMed |
| 41917811 | Targeting mutant p53 in cancer: from mechanistic insights to therapeutic strategies. | Cell Mol Biol Lett | 2026 | https://conductscience.org/library/papers/41917811 | PubMed |
| 41807394 | CF2H: a cell-free two-hybrid platform for rapid protein binder screening. | Nat Commun | 2026 | https://conductscience.org/library/papers/41807394 | PubMed |
| 41764184 | Evaluation of non-canonical p53 functions in DNA replication and recombination for variant classification. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41764184 | PubMed |
| 41688727 | The TP53 gene contains a diversity box that makes it more than a tumor suppressor. | Cell Death Differ | 2026 | https://conductscience.org/library/papers/41688727 | PubMed |
| 41683580 | Targeting ATR-CHK1 and ATM-CHK2 Axes in Pancreatic Cancer-A Comprehensive Review of Literature. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41683580 | PubMed |
| 41552434 | Restoration of the Y220C p53 Full-Length Mutant by PK11000: a Molecular Dynamics Study of an Intrinsically Disordered Protein. | ACS Omega | 2026 | https://conductscience.org/library/papers/41552434 | PubMed |
| 40704418 | Dominant-Negative Effects of p53 R337 Variants in Li-Fraumeni Syndrome: Impact on Tetramer Formation and Transcriptional Activity. | Chembiochem | 2025 | https://conductscience.org/library/papers/40704418 | PubMed |
| 40690375 | Δ133p53α and Δ160p53α isoforms of the tumor suppressor protein p53 exert dominant-negative effect primarily by co-aggregation. | Elife | 2025 | https://conductscience.org/library/papers/40690375 | PubMed |
| 40334261 | Correlation of p53 oligomeric status and its subcellular localization in the presence of the AML-associated NPM mutant. | PLoS One | 2025 | https://conductscience.org/library/papers/40334261 | PubMed |
| 40233742 | Integration of protein stability and AlphaMissense scores improves bioinformatic impact prediction for p53 missense and in-frame amino acid deletion variants. | Am J Hum Genet | 2025 | https://conductscience.org/library/papers/40233742 | PubMed |
| 40233741 | Structural biology in variant interpretation: Perspectives and practices from two studies. | Am J Hum Genet | 2025 | https://conductscience.org/library/papers/40233741 | PubMed |
| 40001547 | The Role of p53 Mutations in Early and Late Response to Mitotic Aberrations. | Biomolecules | 2025 | https://conductscience.org/library/papers/40001547 | PubMed |
| 39944631 | Side-stepping the guardian of the genome: current cancer therapeutics targeting mutant p53. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/39944631 | PubMed |
| 39634561 | Clustering of TP53 variants into functional classes correlates with cancer risk and identifies different phenotypes of Li-Fraumeni syndrome. | iScience | 2024 | https://conductscience.org/library/papers/39634561 | PubMed |
| 39520074 | The Ashkenazi-Centric G334R Variant of TP53 is Severely Impaired for Transactivation but Retains Tumor Suppressor Function in a Mouse Model. | Mol Cell Biol | 2024 | https://conductscience.org/library/papers/39520074 | PubMed |
| 39309126 | Navigating the complexity of p53-DNA binding: implications for cancer therapy. | Biophys Rev | 2024 | https://conductscience.org/library/papers/39309126 | PubMed |
| 39294166 | Germline variant affecting p53β isoforms predisposes to familial cancer. | Nat Commun | 2024 | https://conductscience.org/library/papers/39294166 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TP53 | 7157 | Swiss-Prot's references | https://conductscience.org/library/genes/7157 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7878469
GET https://conductscience.org/api/papers/v1/7878469/cited_by?page=2